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under configuration management control of the Human Research Program 
Control Board (HRPCB). 
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1. INTRODUCTION 
1.1 PURPOSE 
The purpose of this document is to define, document, and allocate the Human 
Research Program (HRP) requirements to the HRP Program elements. It 
establishes the flow-down of requirements from Exploration Systems Mission 
Directorate (ESMD) and Office of the Chief Health and Medical Officer (OCHMO) 
to the various Program Elements of the HRP to ensure that human research and 
technology countermeasure investments are made to insure the delivery of 
countermeasures and technologies that satisfy ESMD’s and OCHMO’s 
exploration mission requirements. 
1.2 SCOPE 
Requirements driving the HRP work and deliverables are derived from the 
exploration architecture, as well as Agency standards regarding the maintenance 
of human health and performance. Agency human health and performance 
standards will define acceptable risk for each type and duration of exploration 
mission. It is critical to have the best available scientific and clinical evidence in 
setting and validating these standards. In addition, it is imperative that the best 
available evidence on preventing and mitigating human health and performance 
risks is incorporated into exploration mission and vehicle designs. These 
elements form the basis of the HRP research and technology development 
requirements and highlight the importance of HRP investments in enabling 
NASA’s exploration missions. 
HRP requirements are derived from the Exploration Architecture Requirements 
Document – Section TBD, ESMD Implementation Plan – Page 18 1st paragraph 
(NP-2006-11-448-HQ), NASA Space Flight Human Systems Standards, Volume 
I: Crew Health (SFHSS Vol. 1), and NASA Space Flight Human Systems 
Standards, Volume II: Habitability and Environmental Health (SFHSS Vol. 2). 
This PRD defines the requirements of the HRP which is comprised of the 
following major Program Elements: Behavioral Health and Performance, 
Exploration Medical Capability, Human Health Countermeasures, ISS Medical 
Project, Space Human Factors and Habitability, and Space Radiation. The 
requirements are divided into the following three categories:  1) human system 
standards (section 4), 2) human health & performance risks (section 5) and 3) 
provisions of enabling capabilities (section 6). 
HRP requirements, as defined in this document, are allocated to the Program 
Office and its Program Elements. Where appropriate, the Program Elements 
further allocate requirements to their research and technology development 
projects. These allocations are documented in the Element/Project plans.  
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Project plans describe specific endpoint deliverables that are linked to Project 
requirements. 
1.3 CHANGE AUTHORITY 
This document is under Configuration Management control of the Human 
Research Program Control Board (HRPCB). Changes to this document will result 
in issuance of change pages or a full re-issue of the document. Review of the 
PRD will be performed and changes made as necessary to maintain consistency 
with the evolving ESMD strategies, goals, and objectives. 
2. DOCUMENTS 
2.1 APPLICABLE DOCUMENTS 
The following documents of the specified revision or the latest revision if not 
identified, are applicable to the extent specified herein. Inclusion of applicable 
documents herein does not in any way imply any order of precedence. 
Document No. Revision Document Title 
SFHSS Vol. 1  NASA Space Flight Human Systems Standards, 
Volume I: Crew Health 
SFHSS Vol. 2  NASA Space Flight Human Systems Standards, 
Volume II: Habitability and Environmental Health  
HRP 47051  Human Research Program – Program Plan 
NPD 1000.0 August 2005 NASA Strategic Management and Governance 
Handbook 
NPD 8500.1 Revision A NASA Environmental Management 
NPD 8910.1 Revision A Care and Use of Animals 
NPR 1080.1 February 2, 2005 NASA Science Management 
NPR 2190.1 April 10, 2003 NASA Export Control Program 
NPR 2810.1 August 26, 1999 Security of Information Technology 
NPR 5800.1 May 19, 2005 NASA Grant and Cooperative Agreement 
Handbook 
NPR 7100.1 March 28, 2003 Protection of Human Research Subjects 
NPR 7120.5 Revision C & D NASA Program and Project Management 
Processes and Requirements 
NPR 8000.4 April 25, 2002 Risk Management Procedural Requirements 
NPR 7123.1A March 26, 2007 NASA Systems Engineering Process and 
Requirements 
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2.2 REFERENCE DOCUMENTS 
The following documents contain supplemental information to guide the user in 
the application of this document. These reference documents may or may not be 
specifically cited within the text of the document. 
HRP-TBD # HRP Integrated Research Plan 
NASA/SP-2004-6113 Bioastronautics Roadmap 
S.1281 National Aeronautics and Space Administration 
(NASA) Authorization Act of 2005 
NSPD31 National Security Presidential Directive 31 – The 
Vision for Space Exploration 
ESMD-TBD # Exploration Architecture Requirements Document 
NP-2006-11-448-HQ ESMD Implementation Plan 
HRP 47053 HRP Science Management Plan 
JSC 28330 SLSD Configuration Control Management Plan 
NPD 7100.8 Protection of Human Research Subjects 
3. HRP GOALS 
This section reflects the HRP Goals and Objectives described in the HRP 
Program Commitment Agreement and the HRP Program Plan (HRP 47051). 
3.1 THE GOAL OF THE HRP IS TO PROVIDE HUMAN HEALTH & 
PERFORMANCE COUNTERMEASURES, KNOWLEDGE, 
TECHNOLOGIES, & TOOLS TO ENABLE SAFE, RELIABLE, & 
PRODUCTIVE HUMAN SPACE EXPLORATION.  THE SPECIFIC 
OBJECTIVES OF THE HRP ARE: 
3.1.1 Develop capabilities, necessary countermeasures, and technologies in 
support of human space exploration, focusing on mitigating the highest 
risks to crew health and performance. Enable the definition and 
improvement of human spaceflight medical, environmental and human 
factors standards. 
3.1.2 Develop technologies that serve to reduce medical and environmental 
risks, to reduce human systems resource requirements (mass, volume, 
power, data, etc.) and to ensure effective human-system integration 
across exploration mission systems. 
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3.1.3 Ensure maintenance of Agency core competencies necessary to enable 
risk reduction in the following areas: space medicine, physiological and 
behavioral effects of long duration spaceflight on the human body, space 
environmental effects, including radiation, on human health and 
performance and space human factors. 
4. HRP REQUIREMENTS RELATED TO HUMAN SYSTEM 
STANDARDS  
4.1 THE HUMAN RESEARCH PROGRAM SHALL ENABLE THE 
DEVELOPMENT AND VALIDATION OF NASA’s HEALTH, 
MEDICAL, HUMAN PERFORMANCE, & ENVIRONMENTAL 
STANDARDS IN TIME FOR EXPLORATION MISSION PLANNING 
& DESIGN. 
Rationale: A first step in mitigation of human health and performance risks 
is the establishment of human spaceflight health standards. These 
standards are designed to address acceptable levels of human health risk 
for exploration missions of varying complexity and duration. The NASA 
Chief Health and Medical Officer has established an initial set of standards 
that serve to guide the Human Research Program in the expansion of 
evidence base regarding human spaceflight health and performance risks.   
HRP sponsors research and technology development enabling 
modification or development of OCHMO maintained standards. 
Several different types of standards have been established by the Chief 
Health and Medical Officer, and documented in Space Flight Human 
Systems Standards, Vol. 1 and Vol. 2. Specifically, the standards sets are 
listed below.   
• Fitness-for-duty standards for maintaining the physiological and 
behavioral parameters necessary to perform the required tasks; 
• Permissible outcome limits for the changes in health outcomes that are 
potentially affected by long-term exposure to the space environment;  
• Permissible exposure limits for managing risks by controlling human 
exposure; 
• Levels of care standards for guiding medical capabilities needed to 
respond to a medical contingency during exploration missions; and 
• Human factors and environmental standards to guide the development 
of spacecraft and systems so as to alleviate human health and 
performance impacts. 
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The Human Research Program requirements necessary to ensure the best 
possible evidence base in order to enable the development of standards are 
included in this section: 
4.1.1 The Human Health Countermeasures (HHC) Program Element shall 
perform the research necessary to enable the development and validation 
of the Fitness for Duty Aerobic Capacity standard. 
4.1.2 The HHC Program Element shall perform the research necessary to 
enable the development and validation of the Fitness for Duty 
Sensorimotor standard. 
4.1.3 The HHC Program Element shall perform the research necessary to 
enable the development and validation of the Fitness for Duty Hematology 
and Immunology standard. 
4.1.4 The HHC Program Element shall perform the research necessary to 
enable the development and validation of the Permissible Outcome Limit 
for Nutrition standard. 
4.1.5 The HHC Program Element shall perform the research necessary to 
enable the development and validation of the Permissible Outcome Limit 
for Muscle Strength standard. 
4.1.6 The HHC Program Element shall perform the research necessary to 
enable the development and validation of the Permissible Outcome Limit 
for Microgravity Induced Bone Mineral Loss Performance standard. 
4.1.7 The HHC Program Element shall perform the research and ensure the 
technology availability to ensure the Levels of Care standards in 
pharmacology can be met for each exploration mission. 
4.1.8 The HHC Program Element shall perform the research and technology 
development necessary to enable the development of the Extravehicular 
Activity sections of the Spaceflight Human Systems Standard, Vol.2. 
4.1.9 The Behavioral Health and Performance (BHP) Program Element shall 
perform the research necessary to enable the development and validation 
of the Fitness for Duty Behavioral Health and Cognition standard. 
4.1.10 The BHP Program Element shall perform the research necessary to 
enable the development of the Circadian Entrainment and Workload 
sections of the Spaceflight Human Systems Standard, Vol. 2. 
4.1.11 The Space Radiation Program Element shall perform the research 
necessary to enable development and validation of the Space Permissible 
Exposure Limit for Space Flight Radiation Exposure standard. 
4.1.12 The Space Radiation Program Element shall perform the research and 
technology developments necessary to enable the development of the 
Radiation sections of the Spaceflight Human Systems Standard, Vol. 2. 
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4.1.13 The Space Human Factors and Habitability (SHFH) Program Element 
shall perform the research necessary to enable development and 
validation of the Permissible Exposure Limit Lunar Dust Inhalation 
standard. 
4.1.14 The Exploration Medical Capability (ExMC) Program Element shall 
perform the research and ensure technology availability in order to ensure 
that Levels of Care standards can be met for each exploration mission. 
4.1.15 The SHFH Program Element shall perform the research and technology 
developments necessary to enable the development of the Spaceflight 
Human Systems Standard, Vol. 2. 
5. HRP REQUIREMENTS RELATED TO HUMAN HEALTH & 
PERFORMANCE RISKS 
The primary objective of the Human Research Program is to enable 
prevention and mitigation of human health and performance risks to enable 
successful completion of exploration missions, and preservation of 
astronaut health over the long-term.  
A key component of the HRP risk mitigation strategy is adoption of an 
occupational health model of managing astronaut health in the hazardous 
environment of space.  In this model, NASA seeks the most comprehensive 
evidence base possible, including medical data obtained over 40 years of 
space operations, and data obtained via research protocols.   
The HRP also seeks to strengthen its partnerships with international space 
agencies, NSBRI, ground based research clinicians in major medical 
centers, and the emerging commercial space transportation industry in 
order to provide the most extensive evidence base possible.  In this way, 
we will maximize our ability to understand and reduce health and 
performance risks. 
Per the HRP Program Plan, the Bioastronautics Roadmap (BR) was used 
as a starting-point reference document. The BR identifies risks, potential 
risks and areas of concerns, but it does not capture the level of detail 
necessary to prioritize across discipline or compare strategies for a given 
risk across mission architectures. Therefore, the Space Life Sciences 
Directorate developed the risk mitigation analysis tool (RMAT).  
The RMAT format reviews medical risks in terms of probability, impact, and 
proposals for mitigating the risks, and reviews each risk in terms of multiple 
mission architectures (short-duration Earth-orbital mission, ISS 6-month 
mission, ISS 12-month mission, short-duration Lunar sortie, long-duration 
Lunar mission, and Mars Mission).  Costs and risks are weighed against the 
probabilities of success of investing in developing a given risk mitigation 
proposal. This approach facilitates analysis of the risk across the different 
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mission architectures and across underlying risk factors for a given 
architecture and will assist with resource allocation to address these risks. 
The HRP conducted an extensive review of medical research findings that 
led to the identification of a series of risks and contributing risk factors. 
Table 1 contains items for which substantial evidence exists, while Table 2 
contains items of concern that cannot be supported or refuted by available 
information.   These risks and contributing factors are dynamic.  New risks 
may be identified with further mission experience, while some 
risks/contributing factors may be retired, if evidence is gathered that refutes 
their importance.  The HRP shall periodically review available information 
and revise these risks/contributing factors as appropriate.   
As an example, future research may determine that microgravity exposure 
does not lead to heart rhythm disturbances, which would allow that risk to 
be retired.  To facilitate such reviews, the HRP will compile spaceflight 
medical research data in a centralized, well-cataloged and retrievable 
database.  The HRP will also strengthen partnerships with international 
space agencies, ground-based research clinicians in academic medical 
centers, and the commercial space transportation industry, to ensure that 
the spaceflight medical database is as complete and robust as possible.   
Table 1, Exploration Missions Human Health and Performance Risks 
Substantiated by a Strong Evidence Base 
Applicable 
HRP Element 
 
Risk and Risk Definition 
HHC Risk of Accelerated Osteoporosis 
Bone mineral loss occurs in microgravity due to unloading of the skeletal system, 
with average loss rates of approximately 1% per month.  It is unclear whether this 
bone mineral density will stabilize at a lower level, or continue to diminish.  It is 
unknown if fractional gravity, present on the moon and Mars would mitigate the 
loss. Mission-related bone loss cannot be corrected by post-mission rehabilitation; 
crewmembers could be at greater risk of osteoporosis-related fractures in later life. 
Greater understanding of the mechanisms of bone demineralization in microgravity 
is necessary to frame this risk, as well as to understand how current and future 
osteoporosis treatments may be employed. 
 
HHC 
Risk of Orthostatic Intolerance During Re-Exposure to Gravity 
Post-flight orthostatic intolerance, the inability to maintain blood pressure while in 
an upright position, is an established, space-related medical problem,   
Countermeasures have been successfully identified and implemented (fluid 
loading, compression garments) or being evaluated (midodrine & others).  
Completion of these efforts will be useful in determining what preventive measures 
should be used to combat orthostatic intolerance during future mission profiles. 
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Applicable 
HRP Element 
 
Risk and Risk Definition 
HHC Risk of Unnecessary Operational Limitations due to Inaccurate Assessment of 
Cardiovascular Performance 
Current inflight indicators of cardiac performance may not accurately reflect 
astronauts cardiovascular performance. Making operational decisions based on 
inaccurate cardiac performance measures may unnecessarily restrict 
crewmembers for critical activities or, more seriously, could subject crewmembers 
to activities for which they are not physically prepared. Accurate measurement of 
crewmember aerobic capacity can eliminate this risk. 
HHC Risk Factor of Inadequate Nutrition 
It is critical that crew members be adequately nourished before and during 
missions.  Critical research areas within this risk include: validation of the correct 
nutritional needs; assessment of the stability of nutrients during long duration flight; 
correct packaging and preservation techniques; effects of countermeasures on 
nutrition; and use of nutrients as countermeasures. 
SHFH Risk Factor of Inadequate Food System 
If the food system does not adequately provide for food safety, nutrition and taste, 
then crew health and performance and the overall mission may be adversely 
affected.  
SHFH Risk Factor of an Inefficient Food System 
If the food system uses more than its allocated mission resources, then total 
required mission resources may exceed capabilities, the mission deemed 
unfeasible, or allocation of resources to other systems may be unduly constrained. 
ExMC Risk of Inability to Adequately Treat an Ill or Injured Crew Member 
Mission architecture limits the amount of equipment and procedures that will be 
available to treat medical problems.  Resource allocation and technology 
development must be performed to ensure that the limited mass, volume, power, 
and crew training time be efficiently utilized to provide the broadest possible 
treatment capability.  This allocation must also consider that not all medical 
conditions are treatable, given the limited resources, and some cases may go 
untreated. 
HHC Risk of Compromised EVA Performance and Crew Health Due to Inadequate EVA 
Suit Systems 
Improperly designed EVA suits can result in the inability of the crew to perform as 
expected, and can cause mechanical and decompression injury.  Suit developers 
must fully understand the impact of the suit design on crew performance and 
health to ensure properly designed mobility, pressures, nutrition, life support, etc. 
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Applicable 
HRP Element 
 
Risk and Risk Definition 
HHC Risk of Urinary Tract Dysfunction
Multiple cases of urinary retention and subsequent urinary tract infections have 
been observed during short duration spaceflight, chiefly among females.  It is not 
clear why exposure to microgravity adversely affects the functioning of the urinary 
tract.  Further research into this area could explain this phenomenon, and assist 
with the clinical management of these cases. 
HHC Risk of Impaired Vision due to Refractive Visual Changes During Long Duration 
Spaceflight 
Significant changes in visual refraction have been documented among ISS 
crewmembers.  These changes appear to be due to senescent accommodative 
changes that may be exacerbated by the small volume of spacecraft cabins.  
Vascular engorgement of retinal support layers also appear to play a role.  Not all 
crewmembers suffer from this problem.  Identification of associated risk factors, 
underlying pathophysiology, and mitigation strategies are necessary for 
maintaining crew vision during long duration missions. 
SHFH Risk of Error Due to Inadequate Information 
Operator errors are common in all work environments.  Task errors during human 
spaceflight missions could have drastic consequences.  Errors can be due to lack 
of information which in turn may be due to any of the following: (a) lack of 
situational awareness, which can be due to poorly designed interfaces, poorly 
designed tasks, or cognitive decrements due to, e.g., fatigue or exposure to toxic 
environments; (b) forgetting, which can be due to inadequate training, poorly 
designed procedures, or to cognitive decrements due to, e.g., fatigue or exposure 
to toxic environment; (c) inability to access appropriate data and procedures due to 
poorly designed interfaces, poorly designed tasks, or to cognitive decrements due 
to, e.g., fatigue or exposure to toxic environments; or (d) failure of judgment due to 
incorrectly perceived or interpreted cues, inappropriately estimated results of 
decisions, or inadequate data.  The risk is currently based on extensive data from 
commercial aviation, from nuclear power plant operations, and from other activities 
with high dependence on technology under sustained operations.  The HRP must 
provide standards for reducing operator errors in spaceflight through adequate 
understanding of causes and mitigations of operator errors. 
BHP Risk of Behavioral and Psychiatric Conditions  
Behavioral issues are inevitable among groups of people, no matter how well 
selected and trained. Spaceflight demands can heighten these issues. The 
Institute of Medicine (IOM) report, Safe Passage, notes that Earth analog studies 
show an incidence rate of behavioral problems ranging from 3-13 percent per 
person per year. The report transposes these figures to 6-7 person crew on a 3-
year mission to determine that there is a significant likelihood of psychiatric 
conditions emerging.  
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Applicable 
HRP Element 
 
Risk and Risk Definition 
Impacts of behavioral issues are minimized if they are identified and addressed 
early. The HRP must provide the best measures and tools to monitor and assess 
mood and to predict risk for and management of behavioral and psychiatric 
conditions prior, during and following spaceflight. 
BHP Risk of Performance Errors Due to Sleep Loss, Circadian Desynchronization, 
Fatigue, and Work Overload 
Fatigue occurs during spaceflight and will jeopardize health and performance.  
This risk may be influenced by artificial and transmitted light exposure, individual 
vulnerability to sleep loss and circadian dynamics, and work/sleep schedules.  
Efforts are needed to improve sleep hygiene, and to identify and improve 
conditions that interfere with sleep quality.  Research areas may include: 
development of a self-assessment tool for cognitive function and fatigue, light 
therapy for phase shifting, alertness and mood disorders, and other means to 
improve sleep quality and reduce fatigue. 
Space 
Radiation 
Risk of Radiation Carcinogenesis 
Occupational radiation exposure from the space environment may increase cancer 
morbidity or mortality risk in astronauts. This risk may be influenced by other space 
flight factors including microgravity and environmental contaminants. A Mars 
mission will not be feasible unless improved shielding is developed or transit time 
is decreased.
Space 
Radiation 
Risk of Acute Radiation Syndromes Due to Solar Particle Events 
Radiation and synergistic effects of radiation may place the crew at significant risk 
for acute radiation sickness from a major solar event or artificial event, such that 
the mission or crew survival may be placed in jeopardy. Crew health and 
performance may be impacted by acute solar events. Beyond Low Earth Orbit, the 
protection of the Earth's atmosphere is no longer available, such that increased 
shielding and protective mechanisms are necessary in order to prevent acute 
radiation sickness and impacts to mission success or crew survival. The primary 
data available at present are derived from analysis of medical patients and 
persons accidentally exposed to high doses of radiation.  Data more specific to the 
spaceflight environment must be compiled to quantify the magnitude of increase of 
this risk and to develop appropriate protection strategies.
SHFH Risk Associated with Poor Task Design 
Errors are often related to poor task design.  Critical tasks must be designed to 
minimize operator error.  Automation, feedback and other task design elements 
may be used in these cases. Multiple actors, including robots, present a unique 
risk. 
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Applicable 
HRP Element 
 
Risk and Risk Definition 
HHC Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and Endurance 
There is a growing research database which suggests that skeletal muscles, 
particularly postural muscles of the lower limb, undergo atrophy and structural and 
metabolic alterations during spaceflight.  However, the relationships between in-
flight exercise, muscle changes and performance levels are not well understood. 
Efforts should be made to try to understand the current status of in-flight and post-
flight exercise performance capability and what the goals/target areas for 
protection are with the current in-flight exercise program.    
HHC Risk of Operational Impact of Prolonged Daily Required Exercise 
Muscle atrophies in microgravity and strength decreases.  Currently, significant 
daily time is scheduled to crew exercise.  Making the exercise more efficient may 
allow similar beneficial effects to be achieved more simply, and in shorter time, 
which would provide more crew time for operational support.  Benchmarking crew 
strength requirements, and testing exercise equipment and regimens against 
these benchmarks, will promote the development of more efficient, yet equally 
safe, exercise regimens. 
Table 2, Exploration Missions Human Health and Performance Risks 
Requiring Further Evidence to Substantiate the Risk/Risk Factor 
Applicable 
HRP Element 
 
Risk and Risk Definition 
 
HHC Risk of Bone Fracture 
Bone mineral loss occurs in microgravity due to unloading of the skeletal system, 
with average loss rates of approximately 1% per month.  It is unclear whether this 
bone mineral density will stabilize at a lower level, or continue to diminish.  It is 
also unknown if fractional gravity, present on the moon and Mars would mitigate 
the loss. This level of bone loss does not create an unacceptable risk of fractures 
for ISS missions, but longer missions could create higher fracture risk. The risk of 
fracture during a mission cannot be accurately estimated until mechanisms and 
probabilities of bone overloading during the missions are understood.   Mission-
related bone loss cannot be corrected by post-mission rehabilitation; 
crewmembers could be at greater risk of osteoporosis-related fractures in later life. 
Greater understanding of the mechanisms of bone demineralization in microgravity 
is necessary to frame this risk, as well as to understand how current and future 
osteoporosis treatments may be employed. 
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HHC 
Risk of Intervertebral Disc Damage 
Extended exposures to microgravity (and possibly fractional gravity) may lead to 
an increased risk of spinal nerve compression and back pain. 
 
HHC 
Risk of Renal Stone Formation 
Kidney stone formation and passage has the potential to greatly impact mission 
success and crewmember health for long duration missions.   Alterations in 
hydration state (relative dehydration) and bone metabolism (increased calcium 
excretion) during exposure to microgravity may increase the risk of kidney stone 
formation and it is unclear which mitigation strategy would be the most effective.  
 
HHC 
Risk of Cardiac Rhythm Problems 
Heart rhythm disturbances have been seen among astronauts.  Most of these 
have been related to cardiovascular disease, but it is not clear whether this was 
due to pre-existing conditions or effects of spaceflight.  It is hoped that advanced 
screening for coronary disease has greatly mitigated this risk.  Other heart rhythm 
problems, such as atrial fibrillation, can develop over time, necessitating periodic 
screening of crewmembers’ heart rhythms.  Beyond these terrestrial heart risks, 
some concern exists that prolonged exposure to microgravity may lead to heart 
rhythm disturbances.  Although this has not been observed to date, further 
surveillance is warranted. 
 
HHC 
Risk of Reduced Physical Performance Capabilities Due to Reduced Aerobic 
Capacity 
Astronauts’ physical performance during a mission, including activity in 
microgravity and fractional gravity, is critical to mission success   Setting minimum 
fitness standards and measuring whether crew can maintain these standards will 
document the effectiveness of maintenance regimens.   
HHC Risk of Adverse Health Effects due to Exposure to Hypoxic Environments 
Spacecraft designers strive to maintain a normal terrestrial atmosphere for 
crewmembers; however, frequent EVA’s necessitate decreasing the atmospheric 
nitrogen levels to decrease the risk of decompression sickness.  Decreasing 
nitrogen partial pressure without decreasing oxygen partial pressure creates a 
significant fire risk.  Concerns exist whether crew performance could be adversely 
affected if cabin oxygen pressures are decreased.  Research into human 
performance at lower oxygen partial pressures could lead significant safety 
improvements in the design of future vehicles and missions. 
HHC Risk of Adverse Health Effects due to Prolonged Exposure to Elevated Carbon 
Dioxide Levels 
Available scrubbing technologies cannot lower cabin carbon dioxide levels to 
terrestrial atmospheric concentrations.  Frequent repairs of complex scrubbing 
equipment have led to elevated CO2 levels on multiple occasions.  Crews often 
complain of symptoms that could relate to elevated CO2 levels.  It is unclear how 
chronic exposure to elevated CO2 levels affect human health.  More research is 
necessary. 
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SHFH 
Risk of Adverse Health Affects from Lunar Dust Exposure 
It is clear that prolonged exposure to rock dust is harmful, but it is not clear if 
exposure to regolith dust is more or less harmful that terrestrial rock dust.  
Research into this area may determine if exposure limits need be changed, and/or 
if additional medical treatment capability is required. 
 
HHC 
Risk of Crew Adverse Health Event Due To Altered Immune Response 
Human immune function is altered in- and post-flight, but it is unclear if this change 
leads to an increased susceptibility to disease.  Reactivation of latent viruses has 
been documented in crewmembers, though this reactivation has not been directly 
correlated with the immune changes nor with observed disease.  Further research 
may elucidate whether microgravity exposure impairs the immune system, and 
whether this change represents a health risk to crews. 
HHC Risk of Impaired Ability to Maintain Control of Vehicles and Other Complex 
Systems 
It has been shown that long duration Spaceflight alters sensorimotor function 
which manifests as changes in locomotion, gaze control, dynamic visual acuity, 
and perception. These changes have not specifically been correlated with real time 
performance decrements.  The possible alterations in sensorimotor performance 
are of interest for Mars missions due to the prolonged microgravity exposure 
during transit followed by landing tasks. This risk must be better documented and 
NS changes must be better correlated with performance issues. 
HHC Risk of Therapeutic Failure Due to Ineffectiveness of Medication 
Based on subjective reports, drugs are effective during spaceflight.  Better 
recordkeeping of medication use, efficacy and side effects will be instituted and 
those records will provide evidence for or against this risk.  If medications are 
found to be ineffective, research will be performed to determine if drug metabolism 
is affected by spaceflight.  Studies to determine if spaceflight affects drug stability 
are currently underway. 
BHP Risk of Performance Errors Due to Poor team Cohesion and Performance, 
Inadequate Selection/Team Composition, Inadequate Training, and Poor 
Psychosocial Adaptation 
Human performance errors may occur due to problems associated with working in 
the space environment and incidents of failure of crews to cooperate and work 
effectively with each other or with flight controllers have been observed.  
Interpersonal conflict, misunderstanding and impaired communication will impact 
performance and mission success.  The history of spaceflight crews regarding 
team cohesion, training and performance has not been systematically 
documented.  Tools, training and support methods should be provided to reduce 
the likelihood of this risk and improve crew performance. 
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Space 
Radiation 
Risk of Acute or Late Central Nervous System Affects from Radiation Exposure 
Acute and late radiation damage to the central nervous system (CNS) may lead to 
changes in motor function and behavior, or neurological disorders. Radiation and 
synergistic effects of radiation with other space flight factors may affect neural 
tissues, which in turn may lead to changes in function or behavior. Data specific to 
the spaceflight environment must be compiled to quantify the magnitude of this 
risk.  If this is identified as a risk of high enough magnitude then appropriate 
protection strategies should be employed.  
Space 
Radiation 
Risk of Degenerative Tissue or other Health Affects from Radiation Exposure 
Occupational radiation exposure from the space environment may result in 
degenerative tissue diseases (non-cancer or non-CNS) such as cardiac, 
circulatory, or digestive diseases, as well as cataracts, although the mechanisms 
and the magnitude of influence of radiation leading to these diseases are not well 
characterized. Radiation and synergistic effects of radiation cause increased DNA 
strand and tissue degeneration, which may lead to acute or chronic disease of 
susceptible organ tissues. Data specific to the spaceflight environment must be 
compiled to quantify the magnitude of this risk to determine if additional protection 
strategies are required.  
SHFH Risk of Reduced Safety and Efficiency Due to Poor Human Factors Design 
Inadequate human factors design in the physical work environments (e.g. vehicles, 
tools and tasks) will result in reduced human performance and increase the 
likelihood of errors. Research is needed to provide spaceflight human factors 
design data and design tools in microgravity and partial gravity. 
 
5.1 THE HRP SHALL QUANTIFY THE HUMAN HEALTH & 
PERFORMANCE RISKS ASSOCIATED WITH HUMAN 
SPACEFLIGHT FOR EXPLORATION MISSIONS. 
Rationale: In many cases, there is a large uncertainty associated with the 
risk due to lack of controlled spaceflight (or ground analog) experimental 
evidence. This HRP requirement is to quantifiably describe the likelihood 
and consequences of the risks. The uncertainties associated with these 
quantities should be narrowed to the target values identified by each 
standard or to the greatest extent practical to facilitate proper decisions for 
exploration hardware design and mission design. 
5.1.1 The HRP Science Management Office shall develop ways to improve 
estimates of the integrated human health and performance risk associated 
with human spaceflight for exploration missions.  
Rationale: The overall risk assessment extends beyond a “list” of risks.  
The risks often have inter-relationships and interdependencies.  The SMO 
must evaluate the risks to identify and quantify these inter-relationships 
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and interdependencies, and provide an assessment of the total risk to the 
human system for spaceflight. This will help focus the HRP effort and 
ensure proper decision making. 
5.1.2 The BHP Element shall quantify the BHP-applicable Risks identified in 
Tables 1 & 2. 
5.1.3 The ExMC Element shall quantify the ExMC-applicable Risks identified in 
Tables 1 & 2. 
5.1.4 The HHC Element shall quantify the HHC-applicable Risks identified in 
Tables 1 & 2. 
5.1.5 The SHFH Element shall quantify the SHFH-applicable Risks identified in 
Tables 1 & 2. 
5.1.6 The Space Radiation Element shall quantify the Space Radiation-
applicable Risks identified in Tables 1 & 2. 
 
5.2 THE HRP ELEMENTS SHALL DEVELOP COUNTERMEASURES 
& TECHNOLOGIES TO PREVENT OR MITIGATE ADVERSE 
OUTCOMES OF HUMAN HEALTH & PERFORMANCE RISKS. 
Rationale: Each risk is written with respect to an adverse outcome.  The 
intent of the HRP is to prevent the adverse outcome from occurring.  If that 
cannot be done, the intent is to develop and validate novel 
countermeasures (devices, drugs, procedures, etc) that will mitigate the 
adverse outcome. In this context, “mitigate” means “reduce the severity or 
reduce the probability of the adverse outcome.” 
 5.2.1 The BHP Element shall develop countermeasures and technologies to 
prevent or mitigate adverse outcomes of human health and performance 
risks relevant to BHP (see Tables 1 & 2). 
5.2.2 The ExMC Element shall develop countermeasures and technologies to 
prevent or mitigate adverse outcomes of human health and performance 
risks relevant to ExMC (see Tables 1 & 2). 
5.2.3 The HHC Element shall develop countermeasures and technologies to 
prevent or mitigate adverse outcomes of human health and performance 
risks relevant to HHC (see Tables 1 & 2). 
5.2.4 The SHFH Element shall develop countermeasures and technologies to 
prevent or mitigate adverse outcomes of human health and performance 
risks relevant to SHFH (see Tables 1 & 2). 
5.2.5 The Space Radiation Element shall develop countermeasures and 
technologies to prevent or mitigate adverse outcomes of human health 
and performance risks relevant to Space Radiation (see Tables 1 & 2). 
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5.3 THE HRP ELEMENTS SHALL DEVELOP COUNTERMEASURES 
& TECHNOLOGIES TO MONITOR & TREAT ADVERSE 
OUTCOMES OF HUMAN HEALTH & PERFORMANCE RISKS. 
Rationale: If a risk cannot be mitigated adequately, the human must be 
monitored for indicators of an adverse outcome, and treatment and or 
countermeasures should be developed. 
5.3.1 The BHP Element shall develop countermeasures and technologies to 
monitor and treat adverse outcomes of human health and performance 
risks relevant to BHP (see Tables 1 & 2). 
5.3.2 The ExMC Element shall develop countermeasures and technologies to 
monitor and treat adverse outcomes of human health and performance 
risks relevant to ExMC (see Tables 1 & 2). 
5.3.3 The HHC Element shall develop countermeasures and technologies to 
monitor and treat adverse outcomes of human health and performance 
risks relevant to HHC (see Tables 1 & 2). 
5.3.4 The SHFH Element shall develop countermeasures and technologies to 
monitor and treat adverse outcomes of human health and performance 
risks relevant to SHFH (see Tables 1 & 2). 
5.3.5 The Space Radiation Element shall develop countermeasures and 
technologies to monitor and treat adverse outcomes of human health and 
performance risks relevant to Space Radiation (see Tables 1& 2). 
6. HRP REQUIREMENTS RELATED TO PROVISION OF 
ENABLING CAPABILITIES 
6.1 THE HRP SHALL PROVIDE THE ENABLING CAPABILITY TO 
FACILITATE HUMAN SPACE EXPLORATION WITH RESPECT 
TO THE HUMAN SYSTEM. 
Rationale: Ensuring Human exploration requires some infrastructure or 
activities that do not readily fall into a specific research and technology 
development category. The requirements below are intended to provide 
NASA with the necessary infrastructure or capabilities to implement the 
research and technology work required to update inform and validate 
standards and to address the risks relevant to human exploration. 
In the course of research and technology development, each HRP 
Element may encounter the need to perform studies in a ground-based 
space analog environment (e.g. bed-rest facility, Antarctica, NEEMO).  
Each Element is responsible for the selection and/or validation of the 
appropriate analogs and the necessary planning, integration and 
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execution. Large resource commitments to analog facilities must be 
reflected in the Element Research Plan so that the cost-benefit to the HRP 
is clear. 
6.1.1 The ISS Medical Project (ISSMP) shall plan, integrate, and execute HRP 
research tasks requiring access to space to address standards or reduce 
or eliminate human health and performance risks. 
Rationale: Access to space research platforms, namely the Space 
Transportation System (STS), the ISS and the Crew Exploration Vehicle 
(CEV) (transport to and from the ISS) is required to study and/or validate 
many of the items in sections 4.1 and 5.0.  The ISSMP serves as the 
service to integrate, across all other HRP Elements, and optimize the 
research plans requiring access to space. The ISSMP provides the 
interface to the spaceflight programs to ensure that the research is 
properly planned, integrated and executed with the required data returned 
to the investigator. 
6.1.2 The ExMC shall provide data integration and management function to 
ensure proper handling of and access to HRP data. 
Rationale: Access to data is critically important to advancing the state of 
knowledge of the human system in space. A data integration and 
management function includes the proper archiving of historical research 
data (e.g. The Life Science Data Archive), and organizing medical and 
research data to provide proper security levels, allow queriable access,  
and to provide tools to allow analysis of evidence (e.g. Integrated Medical 
Model). 
6.2 THE HRP SHALL ENSURE PRESERVATION & MAINTENANCE 
OF CORE TECHNICAL CAPABILITY & EXPERTISE IN HUMAN 
RESEARCH & TECHNOLOGY DEVELOPMENT. 
Rationale: The core competencies are those which are necessary to 
maintain and nurture an understanding of the existing evidence base 
regarding risks and adverse outcomes to humans due to spaceflight. This 
core competency involves sustaining and maintaining a dedicated 
workforce and a robust external scientific community. It also requires 
adequate testing laboratory physical plant capability. Preservation and 
maintenance of this capability is necessary to provide stability over the 
multi-decadal implementation of the vision for space exploration. This core 
competency is necessary to facilitate: 
1) Strategic Planning. Identifying, prioritizing the risks to the human 
system and developing long-range plans to quantify, prevent, mitigate, 
and treat the adverse outcomes requires competency of both the 
internal and external community to ensure proper direction to the 
research community for focusing their effort.  
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2) Acquisition development, planning and execution. Acquisition of 
research and technology development is an inherently government 
function that requires core expertise within the civil service to ensure 
that the US Government remains a “smart buyer” with respect to 
research and technology development for the human system. 
3) Operations support for near-real time and real-time operational 
decisions involving the human system and environment. Laboratory 
facilities and the expertise to run them and interpret results are 
necessary to support an ongoing evaluation of the human system 
response to the space environment, and to support the medical 
operations function during a mission. This involves the internal 
community, and to some extent the external community where 
uniquely specialized expertise must be sought. 
 
The requirement is written at the HRP level and not specifically allocated to 
the Elements.  The Program Manager will periodically review the core 
technical capability of the Program Elements and adjust where appropriate. 
 
6.3 EACH HRP ELEMENT SHALL ENSURE THAT THEIR PROCESSES 
& PRODUCTS COMPLY WITH THE NASA POLICY DIRECTIVES & 
NASA PROCEDURAL REQUIREMENTS LISTED IN THE TABLE 
OF APPLICABLE DOCUMENTS IN SECTION 2.1. 
Rationale: The Table of applicable documents includes the NPDs and NPRs 
specifically referenced by the HRP Program Plan (HRP 47051). This 
requirement explicitly states which NPRs and NPDs are applicable to the 
HRP, and ensures that the requirement is flowed down to the element level. 
Identification of specific NPR/NPD applicability falls upon each individual 
Element/Project when the Project Plan is defined. The intent of this 
requirement is to ensure HRP compliance with these documents within the 
normal processes and product development ongoing in the HRP. 
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7. APPENDIX A  ACRONYMS AND ABBREVIATIONS 
BHP Behavioral Health & 
Performance 
BMD Bone Mineral Density 
CEV Crew Exploration 
Vehicle 
CM Configuration 
Management 
CMS Competency 
Management System 
Cx Constellation 
E.G. For Example 
ELEM Element(s) 
ESMD Exploration Science 
Mission Directorate 
EVA Extravehicular Activity 
HHC Human Health 
Countermeasures 
HRP Human Research 
Program 
HRPCB Human Research 
Program Control 
Board 
HRPRD Human Research 
Program 
Requirements 
Document 
IOM Institute of Medicine 
IRP Integrated Research 
Plan 
ISS International Space 
Station 
ISSMP ISS Medical Project 
IVA Intravehicular Activity 
JSC Johnson Space 
Center 
Lab Laboratory 
NASA National Aeronautics 
and Space 
Administration 
NEEMO NASA Extreme 
Environment Mission 
Operations 
NGO Needs, Goals, 
Objectives 
NP NASA Publication 
NPD NASA Procedural 
Directive 
NPR NASA Procedural 
Requirements 
NSPD National Security 
Presidential Directive 
NSTS National Space 
Transportation 
System 
OCHMO Office of the Chief 
Health and Medical 
Office 
PIO Program Integration 
Office 
PRD Program 
Requirements 
Document 
RMAT Risk Mitigation 
Analysis Tool 
SA Space Life Sciences 
Directorate 
SAT Small Assessment 
Team 
SD Space Medicine 
Division 
SHFH Space Human 
Factors & Habitability 
SFHCS Space Flight Health 
Care Standard 
SFHSS Space Flight Human 
System Standard 
SLSD Space Life Sciences 
Directorate 
SMO Science Management 
Office 
SMP Science Management 
Plan 
SSP Space Station 
Program 
STS Space Transportation 
System 
TBD To Be Determined 
U.S. United States 
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